Evidence map›Paper›PMID 32569735›Full record

ReviewMicrobes and infection

Influenza virus glycoprotein-reactive human monoclonal antibodies.

Yanbai Li, Lili Wang, Helong Si, Zhengsen Yu, Shijun Tian, Rong Xiang, Xiaoqian Deng, Ruiying Liang, Shibo Jiang, Fei Yu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Microbes and infection. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yanbai LiCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Lili WangResearch Center of Chinese Jujube, Hebei Agricultural University, Baoding, China.
Helong SiCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Zhengsen YuCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Shijun TianCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Rong XiangCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Xiaoqian DengCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Ruiying LiangCollege of Life Sciences, Hebei Agricultural University, Baoding, China.
Shibo JiangKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, China. Electronic address: shibojiang@fudan.edu.cn.
Fei YuCollege of Life Sciences, Hebei Agricultural University, Baoding, China. Electronic address: shmyf@hebau.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza continues to be a significant public health challenge. Two glycoproteins on the surface of influenza virus, hemagglutinin and neuraminidase, play a prominent role in the process of influenza virus infection and release. Monoclonal antibodies targeting glycoproteins can effectively prevent the spread of the virus. In this review, we summarized currently reported human monoclonal antibodies targeting glycoproteins of influenza A and B viruses.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, NeutralizingEpitopesHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A virusInfluenza B virusNeuraminidaseOrthomyxoviridae InfectionsAntibodies, MonoclonalAntibodies, NeutralizingEpitopesHemagglutinin Glycoproteins, Influenza VirusNeuraminidaseGlycoproteinsHemagglutininInfluenza A virusInfluenza B virusMonoclonal antibodiesNeuraminidase

Identifiers

PMID32569735
PMCPMC7303604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.